Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Alosetron is dosed at 0.01–0.05 mg/kg PO q12h in dogs, per Source not established. The citation previously shown here named no retrievable document; a literature search on 2026-07-31 found no source that states this dose for this species and route. Treat as unverified and confirm against a primary reference before clinical use.. Alosetron is used in dogs for Severe diarrhea-predominant IBS. Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Alosetron in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Lotronex
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.01–0.05 mg/kg | q12h | Investigational; short-term trial | Severe diarrhea-predominant IBS | Weak | Source not established. The citation previously shown here named no retrievable document; a literature search on 2026-07-31 found no source that states this dose for this species and route. Treat as unverified and confirm against a primary reference before clinical use. |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Selective serotonin 5-HT3 receptor antagonist that inhibits visceral afferent activity, reducing colonic motility and secretion.
Risk of ischemic colitis and severe constipation. Very restricted use in human medicine. Minimal veterinary data — investigational only.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Alosetron dose range in dogs, with cited source references: PO 0.01–0.05 mg/kg q12h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Alosetron in dogs: PO.
Cited course lengths for Alosetron in dogs include: Investigational; short-term trial. Duration depends on the indication — match it to the specific dose rule in the table above.
Alosetron is indicated in dogs for: Severe diarrhea-predominant IBS.
These are general warnings for Alosetron across species; consult the dog dosing table above for species-specific guidance. Risk of ischemic colitis and severe constipation. Very restricted use in human medicine. Minimal veterinary data — investigational only.
Why a species-specific page? Alosetron pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.